39 minutes of gold...the messiah (obviously not for all) has spoken. The PAA gladiators are on the march.
What a fantastic team (SAB, Board and Exec Management) linked to Healey and with skill sets able to get MPL trialled, regulatory approved and commercialized. Loved how the good Dr T outlined the benefits each team member brought to PAA.
The obvious take away for me was PAA will not become a standalone pharmaceutical company but its mission is to increase the value of PAA through further trialling of MPL as an effective treatment for a full range of neurodegenerative diseases (MND as the lead) so PAA becomes an attractive and unquestionable TO target for BP or a larger US pharmaceutical company (cashed up Amylyx comes to mind).
Optimism has, the sun has broken through the dark clouds and the world is whole again. Thank you MT.
Ann: PharmAust Presentation, page-20
-
- There are more pages in this discussion • 72 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
0.005(3.03%) |
Mkt cap ! $82.65M | |||
| Open | High | Low | Value | Volume |
| 17.0¢ | 18.0¢ | 16.8¢ | $151.1K | 877.6K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 54714 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 371375 | 7 |
View Market Depth
| Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |